ITGB1 and neoplasm: Thus, based on the striking results using the treatment with anti-CD29 antibody, we decided to analyze tissue/tumor integrity by histology, in addition to several T-cell populations in TdLN and TILs, to determine the mechanism by which the antibody treatment is working.